Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection
Top Cited Papers
- 17 December 2001
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 3 (1) , 83-90
- https://doi.org/10.1038/ni746
Abstract
Natural killer (NK) cells may modulate the development of adaptive immune responses, but until now there has been little evidence to support this hypothesis. We investigated the primary and secondary immunity elicited by various tumor cell lines that express CD70 and interact with CD70 ligand (CD27), which is constitutively expressed on NK cells. CD70 expression enhanced primary tumor rejection in vivo as well as T cell immunity against secondary tumor challenge. Primary rejection of major histocompatibility complex (MHC) class I–deficient RMA-S.CD70 tumor cells was mediated by NK cells and perforin- and interferon-γ–dependent mechanisms. This NK cell–mediated process also efficiently evoked the subsequent development of tumor-specific cytotoxic and T helper type 1 responses to the parental, MHC class I–sufficient, RMA tumor cells. Thus CD27-CD70 interactions provide a key link between innate NK cell responses and adaptive T cell immunity.Keywords
This publication has 55 references indexed in Scilit:
- P-glycoprotein Does Not Protect Cells against Cytolysis Induced by Pore-forming ProteinsPublished by Elsevier ,2001
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- NKT cells are phenotypically and functionally diverseEuropean Journal of Immunology, 1999
- Delayed kinetics of tumor necrosis factor-mediated bystander lysis by peptide-specific CD8+ cytotoxic T lymphocytesEuropean Journal of Immunology, 1998
- Control of lymphocyte function through CD27–CD70 interactionsSeminars in Immunology, 1998
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative TumorsThe Journal of Experimental Medicine, 1998
- Triggering of Natural Killer Cells by the Costimulatory Molecule CD80 (B7-1)Immunity, 1996
- CD27: marker and mediator of T-cell activation?Immunology Today, 1994
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985